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Identity 
Other names: PARP-5a; PARP5A; PARPL; TIN1; 
TINF1; TNKS1; pART5 




Spans 226410 bp, 27 exons. 
Transcription 
9599 bp long mRNA, containing 3984 bp long ORF. 
Protein 
Description 
Isoform 1 (1327 amino acids) contains region with 
homopolymeric runs of His, Pro, and Ser (HPS domain, 
aa 1-181), 15 ankyrin repeats (ANK 1 to 15, aa 215-
934), multimerization domain homologous to the sterile 
alpha motif (SAM domain, aa 1030-1089) and PARP 
catalytic domain (aa 1112-1317). Isoform 2 (643 amino 
acids) contains only HPS domain and 9 ANK repeats. 
Expression 
Ubiquitous, high expression in brain and ganglions, 
skin and cardiac tissue. 
Localisation 
Nuclear and cytoplasmic. 
Function 
Poly(ADP-ribosyl)ation (PARsylation) of target 
proteins: TNKS itself, TNKS2/TNKL, TRF1, IRAP, 
TAB182/TNKS1BP1, EBNA-1, Mcl-1L, Mcl-1S, 
NuMA, AXIN1, AXIN2. 
TNKS PARsylates TRF1 (telomeric repeat-binding 
factor 1), a negative regulator of telomere length 
maintenance. PARsylated TRF1 dissociates from 
telomeres, enhancing telomerase-mediated telomere 
elongation (Smith and de Lange, 2000; Cook et al., 
2002). 
PARsylation of NuMA (nuclear mitotic apparatus 
protein) by TNKS contributes to mitotic spindle pole 
assembly (Sbodio and Chi, 2002). 
TNKS can PARsylate Mcl-1L and Mcl-1S and inhibit 
their anti- and pro-apoptotic function correspondingly 
(Bae et al., 2003). 
TNKS inhibits Epstein-Barr virus OriP function by 
binding and modifying Epstein-Barr nuclear antigen 1 
(EBNA1) (Deng et al., 2002; Deng et al., 2005). 
PARsylation activity of TNKS increases after 
phosphorilation by mitogen-activated protein kinase 
(MAPK) upon insulin stimulation (Chi and Lodish, 
2000). 
TNKS together with its partner IRAP enhances insulin-
stimulated exocytosis of GLUT4 (Yeh et al., 2007). 
TNKS PARsylates AXIN1 and AXIN2 components of 
beta-catenin (the Wnt pathway transcription factor) 
destruction complex (Huang et al., 2009). 
TNKS is a target of the FANCD2, the key protein 
involved in development of Fanconi anemia. FANCD 
binds tankyrase-1 and inhibits its PARsylation at 
telomeres (Lyakhovich et al., 2011). 
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TNKS protein. HPS: region containing homopolymeric runs of His, Pro, and Ser; ANK: ankyrin domain; SAM: multimerization domain 






Frameshift mutations are found in exons 9 and 10 in 





TNKS is considered as a potential target for anticancer 
treatment.  
Inhibition of PARP activities of TNKS blocks 
Wnt/beta-catenin pathway and increases efficiency of 
telomerase inhibitors (Seimiya et al., 2005; Huang et 
al., 2009; Zhang et al., 2010). 
Disease 
TNKS expression increased in some tumors (compared 
to adjacent normal tissues), including breast, bladder 
and gastric cancer (Gelmini et al., 2004; Gelmini et al., 
2007; Poonepalli et al., 2008; Gao et al., 2011), but in 
other tumors, e.g. malignant glioma and colorectal 
cancer TNKS expression might be downregulated 
(Shervington et al., 2007; Shebzukhov et al., 2008), 
Fanconi anemia (Lyakhovich et al., 2011). 
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